Patent · US Active

Sustained release formulation and tablets prepared therefrom

US10207002B2 · kind B2 · utility

1Cited by
0References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 21, 2016
Grant dateFeb 19, 2019
Priority date
Expiry dateJun 21, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/38
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are formulations and tablets made therefrom comprising the compound of Formula IA or Formula IB which have sustained-release properties, and the dispersion containing the compounds of Formula IA or IB which facilitates such sustained release: Formula IA, Formula IB.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.